A Haapalinna

Summary

Country: Finland

Publications

  1. ncbi request reprint Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole
    A Haapalinna
    Orion, Orion Pharma, Preclinical R and D, Turku, Finland
    Eur J Pharmacol 347:29-40. 1998
  2. ncbi request reprint Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats
    A Haapalinna
    Orion Corporation, Orion Pharma, Turku, Finland
    Naunyn Schmiedebergs Arch Pharmacol 359:194-203. 1999
  3. ncbi request reprint The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats
    A Haapalinna
    Orion Pharma, Preclinical R and D, Orion, PO Box 425, Fin 20101, Turku, Finland
    Eur J Pharmacol 387:141-50. 2000
  4. pmc Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302
    J Sallinen
    Orion Corporation Orion Pharma, Research and Development, Turku, Finland
    Br J Pharmacol 150:391-402. 2007
  5. ncbi request reprint Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels
    J Sallinen
    Orion Corporation, Orion Pharma, FIN 20101 Turku, Finland
    Mol Psychiatry 4:443-52. 1999

Detail Information

Publications5

  1. ncbi request reprint Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole
    A Haapalinna
    Orion, Orion Pharma, Preclinical R and D, Turku, Finland
    Eur J Pharmacol 347:29-40. 1998
    ..It has also an effect on a consolidation process unrelated to attentional or motivational mechanisms. In a stressful test. stimulation of noradrenaline release leads to impairment of performance...
  2. ncbi request reprint Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats
    A Haapalinna
    Orion Corporation, Orion Pharma, Turku, Finland
    Naunyn Schmiedebergs Arch Pharmacol 359:194-203. 1999
    ..The results support the role of alpha2-adrenoceptors and noradrenergic system in reactions both to novelty and stress and have possible implications in cognitive functions as well as in depression...
  3. ncbi request reprint The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats
    A Haapalinna
    Orion Pharma, Preclinical R and D, Orion, PO Box 425, Fin 20101, Turku, Finland
    Eur J Pharmacol 387:141-50. 2000
    ....
  4. pmc Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302
    J Sallinen
    Orion Corporation Orion Pharma, Research and Development, Turku, Finland
    Br J Pharmacol 150:391-402. 2007
    ..The current study describes a novel highly selective alpha2C-adrenoceptor antagonist, JP-1302 (acridin-9-yl-[4-(4-methylpiperazin-1-yl)-phenyl]amine)...
  5. ncbi request reprint Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels
    J Sallinen
    Orion Corporation, Orion Pharma, FIN 20101 Turku, Finland
    Mol Psychiatry 4:443-52. 1999
    ....